Statistical Analysis of the EPIRARE Survey on Registries Data Elements
|
|
- Collin Harper
- 5 years ago
- Views:
Transcription
1 Deliverable D9.2 Statistical Analysis of the EPIRARE Survey on Registries Data Elements Michele Santoro, Michele Lipucci, Fabrizio Bianchi
2 CONTENTS Overview of the documents produced by EPIRARE... 3 Disclaimer... 3 I. Introduction... 4 II. Methods... 5 III. Results... 6 IV. Conclusions
3 Overview of the documents produced by EPIRARE Disclaimer The contents of this document is in the sole responsibility of the Authors; The Executive Agency for Health and Consumers is responsible for any use that may be made of the information contained herein. 3
4 EPIRARE WP6 ANALYSIS OF THE EPIRARE SURVEY ON REGISTRIES DATA ELEMENTS Michele Santoro, Michele Lipucci, Fabrizio Bianchi I. Introduction The EPIRARE Survey on the data elements collected by the Rare Disease Registries represents a useful basis to assess the feasibility of developing an information structure common to all Registries. The EPIRARE WP6 carried out exploratory analyses on data collected by the first EPIRARE Survey, which identified the groups of Registries containing quite similar information (cfr. Epirare WP6 - Collection of released documents, 26 th April 2013). By using different statistical approaches and techniques it was possible to identify Registries with common characteristics, which allowed us to classify them in macro-groups defined according to the agglomerative tendencies and associations emerged. A first group of Registries tends to be concentrate on the area of Public Health. A second group of Registries deals mainly with the Clinical Research and it looks highly correlated with the activity of genetic research. A third group is characterized by the actions on Treatment monitoring and Treatment evaluation, but it shows a tendency to pursue also other goals. This third group appears similar to the second one and it is more complex to be defined, although the collection of data on the Treatment activities represents its specific trait. Based on the results obtained by the first Epirare Survey on 219 Registries, the WP6 analyzed data collected by a second Survey concerning Data Elements used by Rare Disease Registries. The questionnaire consists of 45 specific questions addressing to deepen the information collected by Registries. The analyses were aimed to evaluate the feasibility of collecting specific information and assess if the potential capability of collection is different among the different types of 4
5 Registry. This analysis will give information aimed to assess the feasibility of defining data elements common to all Registries and data elements specific for one or more types of Registry. II. Methods The analysis was performed on 147 Registries which responded to the Survey. In order to identify the types of Registry, responders Registries were classified using different sequential criteria. We started to identify the Registries, which operate in the area of Public Health as follows: Registries declaring exclusively the aims belonging to the group: Epidemiological-Public Health as defined in the Survey; Registries declaring to collect data on All rare diseases ; Registries declaring to collect data on many groups of diseases; Registries declaring to be part of network Eurocat. After making crossed and combined checks of the above listed criteria, these Registries have been labeled as "Public Health". Then we explored on a possible classification of the remaining Registries. The Registries that have declared aims for the group "Treatment", have been labeled as "Clinical"; they are Registries involved in clinical research, but without dealing with Treatment. The remaining Registries were classified as "Clinical-Treatment". Two Registries did provide any information on aims and on number of diseases. For these Registries information on the Web were searched in order to classify them. A Multiple Correspondence Analysis was performed using variables characterizing Registries: single aims and number of diseases (one disease, a group of disease, several/all diseases). The scopes of this analysis were: - to verify the associations between variables identified by the first Survey data analysis (cfr. Epirare WP6 - Collection of released documents, Statistical Analysis of the EPIRARE Survey data - Part 1 -, 26 th April 2013) performing again the same technique but on a smaller sample of Registries; - to evaluate the classification of Registries adopted. 5
6 After that, an analysis on the data elements collected by Registries was performed. The distribution of each data element was analyzed stratifying the Registries in the three categories according to the classification described above. The capacity of collection of the data elements (,,, Not Adaptable, ) was distinguished as defined in the questions. A specific focus was made on the Registries that operate in the field of genetic research. The use of the question "Is your Registry able to collect data on Genetic features of the rare disease?", was able to identify these Registries that operate across the field of clinical research and treatment. III. Results Classification of Registries The distribution of the three categories of Registries is reported in Table 1. The 26.5% of Registries falls in the group "Public Health" and the 25.9% in the group called "Clinical". The remaining 47.6% of the Registries is classified in the Group "Clinical-Treatment." Tab.1 Number and Percentage of Registry by Type Number Percentage CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total In order to check the plausibility of the classification, the distribution of the responses to the specific question on the collection of clinical data was analyzed. The results (Tab. 2) clearly show a greater tendency to collect this type of data by "Clinical" and "Clinical-Treatment" Registries, whereas the percentage for the Registries "Public Health" is lower, as expected, even if a high percentage of collected information is worth of e. 6
7 Tab.2: Clinical data CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Interesting results about the distinction of the Registries emerged by the question about the collection of data on patients with a confirmed diagnosis only or also with suspected diagnosis (Tab.3). "Public Health" Registries tend mainly to collect data of patients with a confirmed diagnosis only. Tab.3: Confirmed and suspected diagnosis Confirmed only Both Confirmed and suspected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total In the Figure 1 the factorial plan obtained by Multiple Correspondence Analysis using the variable aims and number of diseases is represented. All the aims relating to the group Epidemiology and Public health (as defined in the Survey) are placed in the upper part of the plan; in the lower part all the aims relating to the groups Clinical and Treatment are collocated. The aims of these 2 groups are placed on the same direction, so it means they are associated, but all the 3 aims of treatment (efficacy, effectiveness and safety) have higher x values on the horizontal axis, that means they are distinguished although slightly. The Registries which deal with several or all rare diseases, are placed in the upper part, opposite to treatment and clinical aims, as expected. This representation confirms the tendency of the Registries to aggregate into three groups: Public Health, Clinical Research, Treatment. 7
8 Fig.1: Factorial plan defined by variables: aims and number of disease; projection of the Registries classification Key connections The need to have a unique key for the identification of the patients is a challenging issue for the interconnection of the Registries. This key, defined here as Key connection, it must be generated through algorithms derived by using personal and demographic information, capable of producing a unique and anonymous code for each patient. In order to ensure the uniqueness of the patient, the following data elements might be at least included: First name, Last name, Sex, Date of birth, City of birth. On the basis of the data collected by the Survey, we estimated the percentage of Registries that would be potentially able to produce the Key connection, in the perspective of identifying the common data elements. The condition for defining a Registry capable to produce the key 8
9 connection, was the collection or adaptability of all the five key variables. Less than half of the responder s Registries, would be potentially capable to produce a Key connection as previously defined. A different collection ability exists among the three types of Registry, with a minor capability for the "Clinical-Treatment" Registries. Considering that the capacity to produce a key connection represents a very critical issue to assess the potential degree of interconnection between Registries and having observed a variability by nation of the Register, a geographical focus has been realized. Checking Registries by country of location, Italian Registries show a higher capability to produce Key connection, whereas only a low percentage of German and British Registries collect all the data needed to calculate the Key (Tab. 5). Tab.4: KEY CONNECTION = First Name + Last name + Sex + Date of birth + City of birth Yes No CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Chi-square test: p value = 0.22 Tab.5: KEY CONNECTION by nation of Registries Yes No Country France Germany Italy Spain UK Not European Countries Other European Countries International Coverage Total In the following tables the distributions of each variable forming the Key connection are reported. Almost all the Registries collect data on gender and date of birth, whereas the data on 9
10 names and place of birth seem to be very critical for the collection. In particular, the Public Health" Registries show difficulties in collecting data on name of patients, whereas the "Clinical" and "Clinical-Treatment" Registries present more deficiencies in collecting data on the city of birth. Tab.6: First name of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.7: Last name of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.8: Gender of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total
11 Tab.9: Date of birth of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.10: City of birth of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Other personal data The Patient's National security code could represent an alternative way to identify the patient ensuring uniqueness and anonymity, but the limited ability to collect this data highlights the criticality of their use (Tab.11). Other personal data were analyzed in function of the definition of Key connection, but mainly for exploring their information content. The city of residence is a variable collected in a consistent way by the Public Health Registries whose action is based on the epidemiological research (Tab.12). This result confirms the trait of this type of Registry and the need to identify specific data elements based on different scopes of the Registries. The responses to the question on the Patient s contact, shows that RD Registries are inclined to collect this information (tab.13). Regarding to the question on the collection of the date of death, about 25% of "Public Health" and "Clinical" Registries declared that they do collect this data (tab.14). It should be taken into consideration that this data is more related with a complex activity of follow-up, or a systematic 11
12 linkage with mortality Registries that could be active in all areas. A relevant coverage of this data element is present on the "Clinical-Treatment" Registries. Tab.11: Patient s national Security Code Collected Adaptable Not collected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.12: City of residence of patient CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.13: Patient s contact CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.14: Date of death CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Diagnosis 12
13 The date of diagnosis is collected by the 64.6% of the Registries; more than 16% collects the information in a potentially adaptable way. About 10% of the Registries does collect this type of data, in particular the "Clinical" Registries. "Clinical-Treatment" Registries show a high capacity to collect this data element. About the date on the onset of the symptoms, the capability of collection is quite low for all Registries, especially for "Public Health" Registries. It should be underlined that such information is difficult to collect because the patient could remind the exact date of onset of the first symptoms. Tab.15: Date of diagnosis CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.16: Date of disease onset CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Health services The data on co-morbidity are recorded in a fairly satisfactory way by the Clinical and Clinical- Treatment Registries, whereas they are inadequately collected by Public health Registries (tab.17). All Registries show a low capability to collect data on hospitalization and on patient s disability (tab.18, tab.19). Tab.17: Comorbidity 13
14 CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.18: Hospitalization CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.19: Patient's disability Collected Adaptable Not collected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Treatment The Survey-question on the treatment with orphan drugs shows a lack of collection, with exception for the Registries classified as Clinical-Treatment, which reaches a satisfactory capability of coverage (tab.20). Clinical-Treatment Registries shows also a higher capacity to collect data on the treatment with other drugs (Tab. 21). 14
15 Tab.20: Current orphan drugs Treatment CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab.21: Current drugs Treatment CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Recruitment The question concerning the willingness to be recruited for clinical trials shows a different response among the types of Registries. About 85% of "Clinical" and "Clinical-Treatment" Registries collects this data, whereas the "Public Health" Registries tend to collect this information in a limited way. The data on donation of biological samples has a real or potential capability of collection in about 70% of "Clinical" Registries and in 85% of "Clinical-Treatment" Registries; "Public Health" Registries show a poor capacity to collect this data. Tab.22: Patient recruitment for Clinical trial Collected Adaptable Not collected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total
16 Tab.23: Patient recruitment for donating biological samples Collected Adaptable Not collected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Genetic data Genetic research is carried out in a clinical setting and across the Registries that operate in the Treatment too. About 60% of "Clinical" Registries declares also to pursue objectives on genetic research; the percentage is higher (about 75%) for "Clinical-Treatment" Registries. As expected, a low percentage of the Registries classified as "Public Health" declares to perform genetic research. Tab.24: Registries with aim of Geype-pheype correlation/mutation database Yes No CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total The distribution of responses to the question on the collection of genetic features clearly shows that this need of information is a characteristic of "Clinical" and "Clinical-Treatment" Registries and of "Public Health" Registries. This distribution represents a further confirmation of the reliability on the classification criteria identified. The Survey requested also to specify the types of genetic data collected in case that the Registries declared previously to collect genetic data. The data on Gene (HGNC Gene Symbol) is collected by 71% of the Registries that collected genetic data; 34% collects HGVS Variant description format, 20% Chromosome number. The other genetic data are collected in a limited way. 16
17 Tab. 25: Genetic features Collected Adaptable Not collected CLINICAL CLINICAL-TREATMENT PUBLIC HEALTH Total Tab. 26: Genetic data collected by Registries which collect Genetic features Number % Data collected Gene (HGNC Gene Symbol) Chromosome number Chromosomal reference sequence accession and version number RefSeqGene accession and version number Locus Reference Genomic (LRG) Variant description in HGVS format Variant description in other format Other
18 IV. Conclusions The results obtained from the analysis of Survey on data elements provide a useful information framework for assessing the feasibility concerning the definition of a Common Data Element (CDE). It appears quite evident, even from this Survey, a different profile of collecting data among the Rare Disease Registries that operate mainly in the field of Public Health and of those which work within the general scope of Clinical research. With few exceptions, the Registries defined as "Clinical" and those operating in the area of treatment - called "Clinical-Treatment" - show common profiles. A first important result, common to the different types of Registries, is the difficulty to build a unique and useful key of interconnection. The critical situation is highlighted in different ways for the types of Registry: the Public Health Registries show more difficulties on collection of the names of the patients, whereas the Clinical Research Registries on the collection of the place of birth. The Public Health Registries tend to collect more data on patients with only confirmed diagnosis. These Registries, being based on an epidemiological function, tend to collect more the data on place of residence. Instead they collect in a limited way the contact information on the patient and almost 30% of this Registries does collect the information on the date of death. This last data element is of particular relevance for the production of accurate estimates on prevalence and survival. This data should be validated by a follow-up of the patient and/or by a linkage with other information systems (mortality, hospitalizations, other registries). For this reason it should be strengthened, for these Registries, the capability of linkage with other health information systems in order to obtain information also on hospitalization, comorbidity and disability. As expected, these Registries do collect clinical and genetic data, data on the treatment, patient recruitment for clinical trials and biospecimen donation. On the other side the Registries conducting clinical research, collect more data on the identification of patient s contact, on co-morbidity, on recruitment for clinical trials. The Clinical research Registries which deal with Treatment, show some expected peculiarities, such as an increased ability to collect data on treatments; they also show a greater attitude to record the date of death and the date of diagnosis. 18
19 The collection of genetic data, as expected, is a trait of the Registries conducting clinical research. The genetic data mostly collected among the Registries that are involved in genetic research, is the data on Gene (HGNC Gene Symbol); 34% also collects the data on the Variant description in HGVS format, only 20% of the Chromosome number. The collection of other genetic data are very limited. The framework shows that the collection of some information are common to all Registries, whereas other information are collected only by some types of Registry. The specific collection of some data elements should be taken into account for the definition of the Common Data Elements. It is desirable that the elaboration of a CDE for Rare Diseases Registries includes data elements with the different information needs. 19
NURSING CARE IN PSYCHIATRY: Nurse participation in Multidisciplinary equips and their satisfaction degree
NURSING CARE IN PSYCHIATRY: Nurse participation in Multidisciplinary equips and their satisfaction degree Paolo Barelli, R.N. - University "La Sapienza" - Italy Research team: V.Fontanari,R.N. MHN, C.Grandelis,
More informationPFF Patient Registry Protocol Version 1.0 date 21 Jan 2016
PFF Patient Registry Protocol Version 1.0 date 21 Jan 2016 Contents SYNOPSIS...3 Background...4 Significance...4 OBJECTIVES & SPECIFIC AIMS...5 Objective...5 Specific Aims... 5 RESEARCH DESIGN AND METHODS...6
More informationStandard procedure and guide for the coding with Orphacodes. Work Package 5. Deliverable 5.2
Work Package 5 Deliverable 5.2 Standard procedure and guide for the coding with Orphacodes Issued on the 30st of May 2017 by the WP5 members of the RD-ACTION European Joint Action This report is part of
More informationUse of social care data for impact analysis and risk stratification
Use of social care data for impact analysis and risk stratification Sunderland CCG 29 August 2014 Executive summary Sunderland CCG currently gets access to secondary care and primary care data through
More informationEuroHOPE: Hospital performance
EuroHOPE: Hospital performance Unto Häkkinen, Research Professor Centre for Health and Social Economics, CHESS National Institute for Health and Welfare, THL What and how EuroHOPE does? Applies both the
More informationFrequently Asked Questions (FAQ) Updated September 2007
Frequently Asked Questions (FAQ) Updated September 2007 This document answers the most frequently asked questions posed by participating organizations since the first HSMR reports were sent. The questions
More informationBasic Concepts of Data Analysis for Community Health Assessment Module 5: Data Available to Public Health Professionals
Basic Concepts of Data Analysis for Community Assessment Module 5: Data Available to Public Professionals Data Available to Public Professionals in Washington State Welcome to Data Available to Public
More informationNational Registriesfor Rare Diseases
National Registriesfor Rare Diseases Luciano Vittozzi National Centre for Rare Diseases, National Institute of Health Rome -Italy The currentsituation Registries serving 24 ERNs (to be developed) hospital-based
More informationNavy and Marine Corps Public Health Center. Fleet and Marine Corps Health Risk Assessment 2013 Prepared 2014
Navy and Marine Corps Public Health Center Fleet and Marine Corps Health Risk Assessment 2013 Prepared 2014 The enclosed report discusses and analyzes the data from almost 200,000 health risk assessments
More informationThe attitude of nurses towards inpatient aggression in psychiatric care Jansen, Gradus
University of Groningen The attitude of nurses towards inpatient aggression in psychiatric care Jansen, Gradus IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationResearch Brief IUPUI Staff Survey. June 2000 Indiana University-Purdue University Indianapolis Vol. 7, No. 1
Research Brief 1999 IUPUI Staff Survey June 2000 Indiana University-Purdue University Indianapolis Vol. 7, No. 1 Introduction This edition of Research Brief summarizes the results of the second IUPUI Staff
More informationEuropean Haemophilia Consortium
European Haemophilia Consortium Response to the European Commission Public Consultation on rare diseases: Europe s challenges The European Haemophilia Consortium 1 (EHC) is a European patient group representing
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 6.8.2013 COM(2013) 571 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on implementation of the Regulation (EC) No 453/2008 of the European Parliament
More informationUnmet health care needs statistics
Unmet health care needs statistics Statistics Explained Data extracted in January 2018. Most recent data: Further Eurostat information, Main tables and Database. Planned article update: March 2019. An
More informationDeliverable 3.3b: Evaluation of the call procedure
Project acronym CORE Organic Plus Project title Coordination of European Transnational Research in Organic Food and Farming Systems Deliverable 3.3b: Evaluation of the call procedure Lead partner for this
More informationMorbidity statistics in the EU
Morbidity statistics in the EU Bridge Health WP8, final meeting, Rome 14 Sep 2017 Platform for population-based registries Marleen De Smedt, Adviser to the DG, Eurostat European Commission 1 Eurostat Eurostat
More informationFleet and Marine Corps Health Risk Assessment, 02 January December 31, 2015
Fleet and Marine Corps Health Risk Assessment, 02 January December 31, 2015 Executive Summary The Fleet and Marine Corps Health Risk Appraisal is a 22-question anonymous self-assessment of the most common
More informationScottish Hospital Standardised Mortality Ratio (HSMR)
` 2016 Scottish Hospital Standardised Mortality Ratio (HSMR) Methodology & Specification Document Page 1 of 14 Document Control Version 0.1 Date Issued July 2016 Author(s) Quality Indicators Team Comments
More informationFACULTY OF PUBLIC HEALTH DEPARTMENT OF PUBLIC HEALTH SCIENCIES
SYNOPSIS Page 1 of 7 FACULTY OF PUBLIC HEALTH DEPARTMENT OF PUBLIC HEALTH SCIENCIES EXAMINATION SYNOPSIS IN SOCIAL MEDICINE 2015/2016 Specialty Medicine, Second year students (January 2016 examination
More informationNazan Yelkikalan, PhD Elif Yuzuak, MA Canakkale Onsekiz Mart University, Biga, Turkey
UDC: 334.722-055.2 THE FACTORS DETERMINING ENTREPRENEURSHIP TRENDS IN FEMALE UNIVERSITY STUDENTS: SAMPLE OF CANAKKALE ONSEKIZ MART UNIVERSITY BIGA FACULTY OF ECONOMICS AND ADMINISTRATIVE SCIENCES 1, (part
More informationCivil Registration in the Sultanate of Oman: Its development and potential implications on vital statistics
GLOBAL FORUM ON GENDER STATISTICS ESA/ STAT/AC.140/8.3 10-12 December 2007 English only Rome,Italy Civil Registration in the Sultanate of Oman: Its development and potential implications on vital statistics
More informationFamilial Hypercholesterolaemia Quality Improvement Tool Instruction Guide
Familial Hypercholesterolaemia Quality Improvement Tool Instruction Guide PRIMIS development of this tool was part supported by independent funding from Amgen. Prepared by PRIMIS January 2017 The University
More informationJH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population
JH-CERSI/FDA Workshop Clinical Trials: Assessing Safety and Efficacy for a Diverse Population Use of Epidemiologic Studies to Examine Safety in Diverse Populations Judy A. Staffa, Ph.D, R.Ph. Director
More informationErasmus Mundus Action 2 Scholarship Holders Impact Survey
Erasmus Mundus Action 2 Scholarship Holders Impact Survey Results Erasmus Mundus Erasmus Mundus Action 2 Scholarship Holders' Impact Survey Results Education, Audiovisual and Culture Executive Agency
More informationEffectiveness of Nursing Process in Providing Quality Care to Cardiac Patients
Effectiveness of Nursing Process in Providing Quality Care to Cardiac Patients Mr. Madhusoodan 1, Dr. S. C. Sharma 2, Dr. MahipalSingh 3 Research Scholar, IIS University, Jaipur (Raj.) 1 S.K.I.M.H. & R.
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »
EUROPEAN COMMISSION Brussels, 11.5.2011 COM(2011) 254 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Report on the interim evaluation of the «Daphne III Programme 2007 2013»
More informationLondon, Brunei Gallery, October 3 5, Measurement of Health Output experiences from the Norwegian National Accounts
Session Number : 2 Session Title : Health - recent experiences in measuring output growth Session Chair : Sir T. Atkinson Paper prepared for the joint OECD/ONS/Government of Norway workshop Measurement
More informationSNOMED CT AND ICD-10-BE: TWO OF A KIND?
Federal Public Service of Health, Food Chain Safety and Environment Directorate-General Health Care Department Datamanagement Arabella D Havé, chief of Terminology, Classification, Grouping & Audit arabella.dhave@health.belgium.be
More informationAssess the individual, community, organizational and societal needs of the general public and at-risk populations.
School of Public Health and Health Services Department of Prevention and Community Health Master of Public Health and Graduate Certificate Health Promotion 2011 2012 Note: All curriculum revisions will
More informationConfronting the Challenges of Rare Disease:
Confronting the Challenges of Rare Disease: SOLUTIONS ACROSS THE ENTIRE PRODUCT LIFE CYCLE The Orphan Drug Act of 1983 brought increased awareness to the need for new treatments for rare disease patients
More informationBCBSM Physician Group Incentive Program
BCBSM Physician Group Incentive Program Organized Systems of Care Initiatives Interpretive Guidelines 2012-2013 V. 4.0 Blue Cross Blue Shield of Michigan is a nonprofit corporation and independent licensee
More informationSATISFACTION FROM CAREGIVERS OF CHILDREN UNDER AGE OF FIVE FOR SURGERY DEPARTMENT OF NATIONAL PEDIATRIC HOSPITAL, PHNOM PENH, CAMBODIA
Original Research Article S113 SATISFACTION FROM CAREGIVERS OF CHILDREN UNDER AGE OF FIVE FOR SURGERY DEPARTMENT OF NATIONAL PEDIATRIC HOSPITAL, PHNOM PENH, CAMBODIA Thol Dawin 1, Usaneya Pergnparn1, 2,
More informationSCHOOL - A CASE ANALYSIS OF ICT ENABLED EDUCATION PROJECT IN KERALA
CHAPTER V IT@ SCHOOL - A CASE ANALYSIS OF ICT ENABLED EDUCATION PROJECT IN KERALA 5.1 Analysis of primary data collected from Students 5.1.1 Objectives 5.1.2 Hypotheses 5.1.2 Findings of the Study among
More informationCoutts Million Dollar Donors Report 2014 RUSSIA FINDINGS
Philanthropy is fast taking root in the lives of wealthy Russian individuals and families, as well as in the culture of corporations. Number of million dollar donations 30% gifted by individuals 20% gifted
More informationImplementation of the Healthy Islands monitoring framework: Health information systems
TWELFTH PACIFIC HEALTH MINISTERS MEETING PIC12/T1 Rarotonga, Cook Islands 16 August 2017 28 30 August 2017 ORIGINAL: ENGLISH Implementation of the Healthy Islands monitoring framework: Health information
More informationLicensed Nurses in Florida: Trends and Longitudinal Analysis
Licensed Nurses in Florida: 2007-2009 Trends and Longitudinal Analysis March 2009 Addressing Nurse Workforce Issues for the Health of Florida www.flcenterfornursing.org March 2009 2007-2009 Licensure Trends
More informationEvaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes
Evaluating adverse events from patient support and market research programs: proposed best practices and regulatory changes 2 nd Adverse Event Reporting and Safety Strategies Summit December 8-9, 2015
More informationEfforts towards improved coordination of data collection at the international level
UNITED NATIONS SECRETARIAT ESA/STAT/AC.91/16 Statistics Division 5 November 2003 Expert Group Meeting to Review the United Nations Demographic Yearbook System 10-14 November 2003 New York English only
More informationSocial and Behavioral Sciences (SBS)
Social and Behavioral Sciences (SBS) 1 Social and Behavioral Sciences (SBS) Courses SBS 5001. Fundamentals of Public Health. 3 Credit Hours. This course encompasses historical and sociocultural approaches
More informationReport on the Pilot Survey on Obtaining Occupational Exposure Data in Interventional Cardiology
Report on the Pilot Survey on Obtaining Occupational Exposure Data in Interventional Cardiology Working Group on Interventional Cardiology (WGIC) Information System on Occupational Exposure in Medicine,
More informationSOReg Annual Report Norway and Sweden Published December SOReg SCANDINAVIAN OBESITY SURGERY REGISTRY
SOReg SCANDINAVIAN OBESITY SURGERY REGISTRY SOReg 2016 Norway-Sweden first joint report Published December 2017 Can be downloaded from http://helse-bergen.no/soreg or www.ucr.uu.se/soreg/ 1 Table of contents
More informationFEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017
FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME EPIDEMIOLOGICAL ANALYSIS OF TUBERCULOSIS BURDEN AT NATIONAL AND SUB NATIONAL LEVEL (EPI ANALYSIS SURVEY) TERMS OF REFERENCE
More informationDevelopment of the Emergency Room Patient Record in Theodor Bilharz Research Institute Hospital
Journal of Health Informatics in Developing Countries www.jhidc.org Vol. 6 No. 1, 2012 Submitted: September 14, 2011 Accepted: February 28, 2012 Development of the Emergency Room Patient Record in Theodor
More informationCHAPTER 3. Research methodology
CHAPTER 3 Research methodology 3.1 INTRODUCTION This chapter describes the research methodology of the study, including sampling, data collection and ethical guidelines. Ethical considerations concern
More informationENTREPRENEURSHIP & ACCELERATION
ENTREPRENEURSHIP & ACCELERATION Questions from the Field Funding Accelerator Programs December 2017 Photo courtesy of MassChallenge Mexico. The GALI team consistently hears questions from accelerators
More informationThe significance of staffing and work environment for quality of care and. the recruitment and retention of care workers. Perspectives from the Swiss
The significance of staffing and work environment for quality of care and the recruitment and retention of care workers. Perspectives from the Swiss Nursing Homes Human Resources Project (SHURP) Inauguraldissertation
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 3.114, ISSN: , Volume 5, Issue 5, June 2017
VIRTUAL BUSINESS INCUBATORS IN SAUDI ARABIA ALAAALFATTOUH* OTHMAN ALSALLOUM** *Master Student, Dept. Of Management Information Systems, College of Business Administration, King Saud University, Riyadh,
More informationJapanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland
PharmaSUG 2015 - Paper SS02 Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland The opinions expressed in this paper and on the following
More informationPsychiatric care in Switzerland: recent evolutions and perspectives. P. Giannakopoulos
Psychiatric care in Switzerland: recent evolutions and perspectives P. Giannakopoulos Recent evolution of mental disorders in Switzerland: epidemiological aspects Mental health problems represent a major
More informationDA: November 29, Centers for Medicare and Medicaid Services National PACE Association
DA: November 29, 2017 TO: FR: RE: Centers for Medicare and Medicaid Services National PACE Association NPA Comments to CMS on Development, Implementation, and Maintenance of Quality Measures for the Programs
More informationResearch Consent Form
Research Consent Form Title of Study: DRI-Renown Health Population Health study Principal Investigator: Joseph Grzymski, PhD Co-Investigators: Christos Galanopoulos, MD; Christopher Rowan, MD Study contact:
More informationOmobolanle Elizabeth Adekanye, RN 1 and Titilayo Dorothy Odetola, RN, BNSc, MSc 2
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 232 1959.p- ISSN: 232 194 Volume 3, Issue 5 Ver. III (Sep.-Oct. 214), PP 29-34 Awareness and Implementation of Integrated Management of Childhood
More informationERN board of Member States
ERN board of Member States Statement adopted by the Board of Member States on the definition and minimum recommended criteria for Associated National Centres and Coordination Hubs designated by Member
More informationERN Assessment Manual for Applicants
Share. Care. Cure. ERN Assessment Manual for Applicants 3.- Operational Criteria for the Assessment of Networks An initiative of the Version 1.1 April 2016 History of changes Version Date Change Page 1.0
More informationModule 3 Identifying Health Problems
Slide 1: Title Slide Module 3 Thank you for joining us for Module 3:. Now that we have defined our community, it s time to identify its priority health problems. Slide 2: Disclosures for Continuing Medical
More informationChapter -3 RESEARCH METHODOLOGY
Chapter -3 RESEARCH METHODOLOGY i 3.1. RESEARCH METHODOLOGY 3.1.1. RESEARCH DESIGN Based on the research objectives, the study is analytical, exploratory and descriptive on the major HR issues on distribution,
More informationAddressing Cost Barriers to Medications: A Survey of Patients Requesting Financial Assistance
http://www.ajmc.com/journals/issue/2014/2014 vol20 n12/addressing cost barriers to medications asurvey of patients requesting financial assistance Addressing Cost Barriers to Medications: A Survey of Patients
More informationGEM UK: Northern Ireland Summary 2008
1 GEM : Northern Ireland Summary 2008 Professor Mark Hart Economics and Strategy Group Aston Business School Aston University Aston Triangle Birmingham B4 7ET e-mail: mark.hart@aston.ac.uk 2 The Global
More informationForm T-1-1: File of Details of Application (items of attached file) Scientific Research B (Generative Research Fields) Outline 1
Form T-1-1: File of Details of Application (items of attached file) Scientific Research B (Generative Research Fields) Outline 1 Proposal for Grant-in-aid (Outline) The Applicant should clearly and succinctly
More informationCase-mix Analysis Across Patient Populations and Boundaries: A Refined Classification System
Case-mix Analysis Across Patient Populations and Boundaries: A Refined Classification System Designed Specifically for International Quality and Performance Use A white paper by: Marc Berlinguet, MD, MPH
More informationNebraska Final Report for. State-based Cardiovascular Disease Surveillance Data Pilot Project
Nebraska Final Report for State-based Cardiovascular Disease Surveillance Data Pilot Project Principle Investigators: Ming Qu, PhD Public Health Support Unit Administrator Nebraska Department of Health
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL
EUROPEAN COMMISSION Brussels, 8.7.2016 COM(2016) 449 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on implementation of Regulation (EC) No 453/2008 of the European Parliament
More informationCAP GEMINI ERNST & YOUNG S OVERALL REPORT OCT 2001 OCT 2002 ONLINE AVAILABILITYOF PUBLIC SERVICES: HOW DOES EUROPE PROGRESS?
CAP GEMINI ERNST & YOUNG S OVERALL REPORT OCT 2001 OCT 2002 ONLINE AVAILABILITYOF PUBLIC SERVICES: HOW DOES EUROPE PROGRESS? WEB BASED SURVEY ON ELECTRONIC PUBLIC SERVICES Prepared by: Cap Gemini Ernst
More informationEuropean Patients Academy (EUPATI) Update
European Patients Academy (EUPATI) Update EMA meeting with patient/consumer organisations 11 Dec 2013 Maria Mavris EURORDIS // EUPATI WP4 Co-Lead For patient-centric medicines R&D and to contribute to
More informationHMSA Physical and Occupational Therapy Utilization Management Guide
HMSA Physical and Occupational Therapy Utilization Management Guide Published November 1, 2010 An Independent Licensee of the Blue Cross and Blue Shield Association Landmark's provider materials are available
More informationNational Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health
National Plans for Rare Diseases The French plan 2005-2008 2008 Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health Political Context Public Health Law of 9 August 2004 100
More informationDepartment of Health. Managing NHS hospital consultants. Findings from the NAO survey of NHS consultants
Department of Health Managing NHS hospital consultants Findings from the NAO survey of NHS consultants FEBRUARY 2013 Contents Introduction 4 Part One 5 Survey methodology 5 Part Two 9 Consultant survey
More informationHMSA Physical and Occupational Therapy Utilization Management Authorization Guide
HMSA Physical and Occupational Therapy Utilization Management Authorization Guide Published Landmark's provider materials are available online at www.landmarkhealthcare.com. The online Physical and Occupational
More informationModel of Care Scoring Guidelines CY October 8, 2015
Model of Care Guidelines CY 2017 October 8, 2015 Table of Contents Model of Care Guidelines Table of Contents MOC 1: Description of SNP Population (General Population)... 1 MOC 2: Care Coordination...
More informationNumber of sepsis admissions to critical care and associated mortality, 1 April March 2013
Number of sepsis admissions to critical care and associated mortality, 1 April 2010 31 March 2013 Question How many sepsis admissions to an adult, general critical care unit in England, Wales and Northern
More informationEuropean Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications
European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients
More informationReal World Evidence in Europe
Real World Evidence in Europe Jessamy Baird, RWE Director Madrid, 20 th October 2014. BEFORE I BEGIN; DISCLAIMERS: Dual perspective: Pharmaceutical: I work for Lilly, but this presentation represents my
More informationWhy ICD-10 Is Worth the Trouble
Page 1 of 6 Why ICD-10 Is Worth the Trouble by Sue Bowman, RHIA, CCS Transitioning to ICD-10 is a major disruption that providers and payers may prefer to avoid. But it is an upgrade long overdue, and
More informationSummary Table of Peer Country Comments. Peer Review on Germany s latest reforms of the long-term care system, Berlin (Germany), January
Austria Tax funded LTC, no LTCI Already long and positive experience with seven care levels Explicit inclusion of dementia as needs-criterion since 2009 Gradual increase of support measures for family
More informationTrait Anxiety and Hardiness among Junior Baccalaureate Nursing students living in a Stressful Environment
Trait Anxiety and Hardiness among Junior Baccalaureate Nursing students living in a Stressful Environment Tova Hendel, PhD, RN Head, Department of Nursing Ashkelon Academic College Israel Learning Objectives
More informationEPSRC Care Life Cycle, Social Sciences, University of Southampton, SO17 1BJ, UK b
Characteristics of and living arrangements amongst informal carers in England and Wales at the 2011 and 2001 Censuses: stability, change and transition James Robards a*, Maria Evandrou abc, Jane Falkingham
More informationReghuram R. & Jesveena Mathias 1. Lecturer, Sree Gokulam Nursing College, Venjaramoodu, Trivandrum, Kerala 2
Original Article Abstract : A STUDY ON OCCURRENCE OF SOCIAL ANXIETY AMONG NURSING STUDENTS AND ITS CORRELATION WITH PROFESSIONAL ADJUSTMENT IN SELECTED NURSING INSTITUTIONS AT MANGALORE 1 Reghuram R. &
More informationAdmissions with neutropenic sepsis in adult, general critical care units in England, Wales and Northern Ireland
Admissions with neutropenic sepsis in adult, general critical care units in England, Wales and Northern Ireland Question What were the: age; gender; APACHE II score; ICNARC physiology score; critical care
More informationCarers Checklist. An outcome measure for people with dementia and their carers. Claire Hodgson Irene Higginson Peter Jefferys
Carers Checklist An outcome measure for people with dementia and their carers Claire Hodgson Irene Higginson Peter Jefferys Contents CARERS CHECKLIST - USER GUIDE 1 OUTCOME ASSESSMENT 1.1 Measuring outcomes
More informationTwenty years of ICPC-2 PLUS
Twenty years of ICPC-2 PLUS the past, present and future of clinical terminologies in Australian general practice Helena Britt Graeme Miller Julie Gordon Who we are Helena Britt - Director,, University
More informationThe Reason-for-Encounter mode of the ICPC: reliable, adequate, and feasible
Scand J Prim Health Care 1989; 7: 99-103 The Reason-for-Encounter mode of the ICPC: reliable, adequate, and feasible FRANS VAN DER HORST, JOB METSEMAKERS, FRANS VISSERS, GERHART SAENGER*, CEES DE GEUS
More informationMeasuring Pastoral Care Performance
PASTORAL CARE Measuring Pastoral Care Performance RABBI NADIA SIRITSKY, DMin, MSSW, BCC; CYNTHIA L. CONLEY, PhD, MSW; and BEN MILLER, BSSW BACKGROUND OF THE PROBLEM There is a profusion of research in
More informationSan Francisco Department of Public Health Policy Title: HIPAA Compliance Privacy and the Conduct of Research Page 1 of 10
Page 1 of 10 TITLE: HIPAA COMPLIANCE: PRIVACY AND THE CONDUCT OF RESEARCH POLICY It is the policy of the San Francisco Department of Public Health (DPH) to maintain the privacy of Protected Health Information
More informationPsychiatric rehabilitation - does it work?
The Ulster Medical Joumal, Volume 59, No. 2, pp. 168-1 73, October 1990. Psychiatric rehabilitation - does it work? A three year retrospective survey B W McCrum, G MacFlynn Accepted 7 June 1990. SUMMARY
More informationUK Cystic Fibrosis Registry. Data sharing policy
UK Cystic Fibrosis Registry Data sharing policy 1 Contents Introduction... 3 The UK Cystic Fibrosis Registry... 3 Governance... 3 Purpose... 3 Scope... 4 Policy... 4 Submitting a request... 4 Quality control...
More informationBuilding blocks of health information: Classifications, terminologies, standards
Global GS1 Healthcare Conference 22-24 June 2010, Geneva Switzerland Building blocks of health information: Classifications, terminologies, standards Bedirhan Ustün & Nenad Kostanjsek WHO Geneva 1 WHO
More informationGeneral practitioner workload with 2,000
The Ulster Medical Journal, Volume 55, No. 1, pp. 33-40, April 1986. General practitioner workload with 2,000 patients K A Mills, P M Reilly Accepted 11 February 1986. SUMMARY This study was designed to
More informationBackground Paper For the Cardiology Audit and Registration Data Standards (CARDS) Conference during Ireland s Presidency of the European Union
Background Paper For the Cardiology Audit and Registration Data Standards (CARDS) Conference during Ireland s Presidency of the European Union Executive Summary The Minister for Health and Children aims
More informationRESEARCH METHODOLOGY
Research Methodology 86 RESEARCH METHODOLOGY This chapter contains the detail of methodology selected by the researcher in order to assess the impact of health care provider participation in management
More informationHMSA Physical & Occupational Therapy Utilization Management Guide Published 10/17/2012
HMSA Physical & Occupational Therapy Utilization Management Guide Published 10/17/2012 An Independent Licensee of the Blue Cross and Blue Shield Association Landmark's provider materials are available
More informationEUROPEAN. Startup Report
EUROPEAN Startup Report 2017 INTRO Despite Europe s slower start, the startup scenes in the United Kingdom, Germany, France, and the Netherlands have become major threats to the United States Silicon Valley
More informationNewborn Screening Programmes in the United Kingdom
Newborn Screening Programmes in the United Kingdom This paper has been developed to increase awareness with Ministers, Members of Parliament and the Department of Health of the issues surrounding the serious
More informationPatient survey report 2004
Inspecting Informing Improving Patient survey report 2004 Mental health survey 2004 Avon and Wiltshire Mental Health Partnership NHS Trust The mental health service user survey was designed, developed
More informationDr Stephen Pavis NHS National Services Scotland
Dr Stephen Pavis NHS National Services Scotland s.pavis@nhs.net The next 25 minutes Brief overview of Scotland and its health service Scotland s vision around data use The Farr Institute What it is? How
More informationPatients Not Included in Medical Audit Have a Worse Outcome Than Those Included
Pergamon International Journal for Quality in Health Care, Vol. 8, No. 2, pp. 153-157, 1996 Copyright
More informationBackground and Issues. Aim of the Workshop Analysis Of Effectiveness And Costeffectiveness. Outline. Defining a Registry
Aim of the Workshop Analysis Of Effectiveness And Costeffectiveness In Patient Registries ISPOR 14th Annual International Meeting May, 2009 Provide practical guidance on suitable statistical approaches
More informationCHAPTER 6 SUMMARY, CONCLUSION, NURSING IMPLICATIONS & RECOMMENDATIONS
260 CHAPTER 6 SUMMARY, CONCLUSION, NURSING IMPLICATIONS & RECOMMENDATIONS In this chapter, the Summary of study, Conclusion, Implications and recommendations for further research are prescribed. 6.1 SUMMARY
More informationSCERC Needs Assessment Survey FY 2015/16 Oscar Arias Fernandez, MD, ScD and Dean Baker, MD, MPH
INTRODUCTION SCERC Needs Assessment Survey FY 2015/16 Oscar Arias Fernandez, MD, ScD and Dean Baker, MD, MPH The continuous quality improvement process of our academic programs in the Southern California
More informationAppendix A Registered Nurse Nonresponse Analyses and Sample Weighting
Appendix A Registered Nurse Nonresponse Analyses and Sample Weighting A formal nonresponse bias analysis was conducted following the close of the survey. Although response rates are a valuable indicator
More informationUK Renal Registry 13th Annual Report (December 2010): Appendix A The UK Renal Registry Statement of Purpose
Nephron Clin Pract 2011;119(suppl 2):c275 c279 DOI: 10.1159/000331785 Published online: August 26, 2011 UK Renal Registry 13th Annual Report (December 2010): Appendix A The UK Renal Registry Statement
More information